SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-17-099723
Filing Date
2017-03-28
Accepted
2017-03-28 16:02:05
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 13D d366105dsc13d.htm SC 13D 54701
2 EX-99.1 d366105dex991.htm EX-99.1 509605
3 EX-99.2 d366105dex992.htm EX-99.2 98699
  Complete submission text file 0001193125-17-099723.txt   664536
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 781-996-4300
Cerulean Pharma Inc. (Subject) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88094 | Film No.: 17718998
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3216 CAMINITO EASTBLUFF, 67 LA JOLLA CA 92037
Business Address 3216 CAMINITO EASTBLUFF, 67 LA JOLLA CA 92037 (858) 395-4483
DARE BIOSCIENCE, INC. (Filed by) CIK: 0001701808 (see all company filings)

IRS No.: 474813108 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D